|
Feb 10
|
Why Illumina (ILMN) Stock Is Trading Lower Today
|
|
Feb 10
|
Barclays downgrades Illumina on China risks, competition
|
|
Feb 10
|
Illumina (ILMN) International Revenue Performance Explored
|
|
Feb 10
|
Why Illumina Inc. (ILMN) Crashed Last Week
|
|
Jan 3
|
Illumina price target lowered to $180 from $184 at Evercore ISI
|
|
Jan 3
|
Here’s Why Illumina, Inc. (ILMN) Is Among The Stocks Targeted By Activist Hedge Funds
|
|
Oct 2
|
Illumina, Inc. (ILMN): A Bull Case Theory
|
|
Sep 30
|
Shareholders in Illumina (NASDAQ:ILMN) are in the red if they invested three years ago
|
|
Sep 13
|
Goldman Thinks Illumina, Inc. (ILMN) Is A Long-Term AI Stock Set To Rally Eventually
|
|
Sep 10
|
Illumina and Exxon Mobile have been highlighted as Zacks Bull and Bear of the Day
|
|
Sep 10
|
Bull of the Day: Illumina (ILMN)
|
|
Aug 29
|
Results of GRAIL's Galleri® Multi-Cancer Early Detection Blood Test in Prostate Cancer Published in JCO Precision Oncology
|
|
Aug 29
|
The Zacks Analyst Blog Highlights DaVita and Illumina
|
|
Aug 28
|
ILMN's TSO Comprehensive IVD Test Secures FDA Approval as CDx
|
|
Aug 28
|
Illumina upgraded, Fiserv initiated: Wall Street's top analyst calls
|
|
Aug 28
|
2 Must-Buy Medical Stocks With Strong Momentum
|
|
Aug 28
|
FDA grants approval to Illumina’s cancer biomarker test with two CDx indications
|
|
Aug 28
|
Illumina wins FDA approval for companion diagnostic cancer test
|
|
Aug 27
|
FDA approves Illumina cancer biomarker test with two companion diagnostics to rapidly match patients to targeted therapies
|
|
Aug 26
|
Top Stock Picks for Week of August 26, 2024
|